Wird geladen...
The Role of Biosimilars in Inflammatory Bowel Disease
Monoclonal antibody biologic therapies, introduced nearly 20 years ago, revolutionized the treatment of inflammatory bowel disease (IBD) and are now well established as the most effective agents available. As the first of these biologic agents starts to come off patent, biosimilar agents have emerge...
Gespeichert in:
| Veröffentlicht in: | Gastroenterol Hepatol (N Y) |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Millennium Medical Publishing
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5193082/ https://ncbi.nlm.nih.gov/pubmed/28035201 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|